-
Something wrong with this record ?
Influence of pertussis toxin pretreatment on the development of L-NAME-induced hypertension
J. Zicha, J. Kuneš, S. Vranková, L. Jendeková, Z. Dobešová, M. Pintérová, O. Pecháňová
Language English Country Czech Republic
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Financing, Organized MeSH
- Hypertension chemically induced metabolism MeSH
- Rats MeSH
- Disease Models, Animal MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Pertussis Toxin MeSH
- Rats, Wistar MeSH
- GTP-Binding Protein alpha Subunits, Gi-Go antagonists & inhibitors metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
High blood pressure (BP) of L-NAME hypertensive rats is maintained not only by the absence of nitric oxide (NO)- dependent vasodilatation but also by the enhancement of both sympathetic and angiotensin II-dependent vasoconstriction. The aim of the present study was to evaluate the role of inhibitory G (Gi) proteins, which are involved in tonic sympathetic vasoconstriction, in the pathogenesis of NO-deficient hypertension. We therefore studied BP response to chronic L-NAME administration (60 mg/kg/day for 4 weeks) in rats in which the in vivo inactivation of Gi proteins was induced by injection of pertussis toxin (PTX, 10 µg/kg i.v.). The impairment of sympathetic vasoconstriction due to PTX-induced Gi protein inactivation prevents the full development of NO-deficient hypertension because BP of PTX-treated rats subjected to chronic L-NAME administration did not reach hypertensive values. Nevertheless, chronic NO synthase inhibition per se is capable to increase moderately BP even in PTX-treated rats. Our data suggest that the sympathetic vasoconstriction is essential for the development of established NO-deficient hypertension.
References provided by Crossref.org
Lit.: 24
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10012660
- 003
- CZ-PrNML
- 005
- 20111210163253.0
- 008
- 100526s2009 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931898 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Zicha, Josef, $d 1950- $7 jk01152609
- 245 10
- $a Influence of pertussis toxin pretreatment on the development of L-NAME-induced hypertension / $c J. Zicha, J. Kuneš, S. Vranková, L. Jendeková, Z. Dobešová, M. Pintérová, O. Pecháňová
- 314 __
- $a Institute of Physiology, Academy of Sciences of the Czech Republic, Prague
- 504 __
- $a Lit.: 24
- 520 9_
- $a High blood pressure (BP) of L-NAME hypertensive rats is maintained not only by the absence of nitric oxide (NO)- dependent vasodilatation but also by the enhancement of both sympathetic and angiotensin II-dependent vasoconstriction. The aim of the present study was to evaluate the role of inhibitory G (Gi) proteins, which are involved in tonic sympathetic vasoconstriction, in the pathogenesis of NO-deficient hypertension. We therefore studied BP response to chronic L-NAME administration (60 mg/kg/day for 4 weeks) in rats in which the in vivo inactivation of Gi proteins was induced by injection of pertussis toxin (PTX, 10 µg/kg i.v.). The impairment of sympathetic vasoconstriction due to PTX-induced Gi protein inactivation prevents the full development of NO-deficient hypertension because BP of PTX-treated rats subjected to chronic L-NAME administration did not reach hypertensive values. Nevertheless, chronic NO synthase inhibition per se is capable to increase moderately BP even in PTX-treated rats. Our data suggest that the sympathetic vasoconstriction is essential for the development of established NO-deficient hypertension.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a proteiny vázající GTP - alfa-podjednotky Gi-Go $x antagonisté a inhibitory $x metabolismus $7 D019206
- 650 _2
- $a hypertenze $x chemicky indukované $x metabolismus $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a NG-nitroargininmethylester $7 D019331
- 650 _2
- $a pertusový toxin $7 D037342
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 700 1_
- $a Kuneš, Jaroslav, $d 1948- $7 nlk19990073450
- 700 1_
- $a Vranková, Stanislava. $7 _AN049189
- 700 1_
- $a Jendeková, Lýdia $7 xx0074917
- 700 1_
- $a Dobešová, Zdena, $d 1947- $7 xx0074152
- 700 1_
- $a Pintérová, Mária $7 xx0102050
- 700 1_
- $a Pecháňová, Oľga, $d 1962- $7 xx0075055
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 58, č. 5 (2009), s. 751-755 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/58/58_751.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8
- 990 __
- $a 20100525095435 $b ABA008
- 991 __
- $a 20100602155836 $b ABA008
- 999 __
- $a ok $b bmc $g 726515 $s 589671
- BAS __
- $a 3
- BMC __
- $a 2009 $b 58 $c 5 $m Physiological research $x MED00003824 $d 751-755
- LZP __
- $a 2010-28/ipme